BrightView(BV) - 2025 Q4 - Earnings Call Presentation
2025-11-20 13:30
Fourth Quarter & Fiscal Year 2025 Earnings Call November 20, 2025 NYSE: BV Introductory Information Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which are subject to the "safe harbor" created by th ...
Compass Therapeutics (NasdaqCM:CMPX) 2025 Conference Transcript
2025-11-20 13:32
Compass Therapeutics (NasdaqCM:CMPX) 2025 Conference November 20, 2025 07:30 AM ET Company ParticipantsThomas Schuetz - Founder, CEO and Vice Chairman of the BoardMaury Raycroft - Equity ResearchMaury RaycroftMy name is Maury Raycroft, and one of the biotech analysts at Jefferies. It's with great pleasure that I'd like to welcome Thomas Schuetz, the CEO of Compass Therapeutics. Thanks so much for joining us today, Thom.Thomas SchuetzThanks, Maury. Thanks for inviting us to the conference. Really appreciate ...
Altus Group (OTCPK:ASGT.F) 2025 Earnings Call Presentation
2025-11-20 13:30
2025 INVESTOR DAY Built for performance November 20, 2025 Welcome! Camilla Bartosiewicz Chief Communications Officer 2 A formidable foundation For over 20 years, Altus has played a vital role in empowering CRE professionals with the data, analytics, and trusted advice they need to make high-stakes decisions – whether to buy, sell, build, or reinvest in commercial real estate assets. The industry's top leaders rely on our market-leading solutions and expertise to power performance and mitigate risk. CANADA 3 ...
VNET(VNET) - 2025 Q3 - Earnings Call Transcript
2025-11-20 13:02
VNET Group (NasdaqGS:VNET) Q3 2025 Earnings Call November 20, 2025 07:00 AM ET Company ParticipantsJu Ma - Rotating PresidentShengguang Liu - Head of Investor RelationsQiyu Wang - CFONone - Unknown Speaker 2Dean Liu - Assistant Vice President, Enterprise CreditNone - Unknown Speaker 1Anthony Leng - Equity Research AssociateSarah Wang - DirectorNone - Unknown Speaker 3Conference Call ParticipantsAndy Yu - AnalystTimothy Zhao - AnalystTom Tang - AnalystOperatorHello, ladies and gentlemen. Thank you for standi ...
NTES(NTES) - 2025 Q3 - Earnings Call Transcript
2025-11-20 13:02
NetEase (NasdaqGS:NTES) Q3 2025 Earnings Call November 20, 2025 07:00 AM ET Company ParticipantsBrandi Piacente - Head of Investor RelationsNone - Company RepresentativeThomas Chong - Managing DirectorBill Pang - VP of Corporate DevelopmentWilliam Ding - CEOJialong Shi - Managing DirectorConference Call ParticipantsYu Qingzeng - AnalystFelix Liu - Lead Analyst and Executive DirectorRitchie Sun - Equity Research AnalystAlicia Yap - Equity Research AnalystLincoln Kong - Equity Research AnalystOperatorGood day ...
ATRenew(RERE) - 2025 Q3 - Earnings Call Transcript
2025-11-20 13:02
ATRenew (NYSE:RERE) Q3 2025 Earnings Call November 20, 2025 07:00 AM ET Company ParticipantsKerry Chen - Founder, Chairman, and CEORex Chen - CFONone - TranslatorJeremy Ji - Head of Corporate DevelopmentConference Call ParticipantsWang Zhao - AnalystNone - AnalystMichael Kim - Senior AnalystOperatorGood morning and good evening, ladies and gentlemen. Thank you for standing by, and welcome to the ATRenew third quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. We ...
Maze Therapeutics (NasdaqGM:MAZE) 2025 Conference Transcript
2025-11-20 13:02
Maze Therapeutics (NasdaqGM:MAZE) 2025 Conference November 20, 2025 07:00 AM ET Company ParticipantsJason Coloma - CEOJason ColomaMorning, everyone. I'm Jason Coloma. I'm the CEO of Maze Therapeutics. First of all, I'd like to thank the Jefferies team for inviting us to this year's conference. I'd also like to acknowledge our forward-looking statements. At Maze, our mission is simple yet ambitious: to harness the power of human genetics to transform the lives of patients. An emphasis for us is chronic kidne ...
Sunlands(STG) - 2025 Q3 - Earnings Call Transcript
2025-11-20 13:02
Sunlands Technology Group (NYSE:STG) Q3 2025 Earnings Call November 20, 2025 07:00 AM ET Company ParticipantsTongbo Liu - CEOYuhua Ye - Head of Investor RelationsHangyu Li - CFOOperatorLadies and gentlemen, thank you for standing by, and welcome to Sunlands' Third Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. Today's conference call is being recorded. I will now turn the call over to your host today, Yuhua, Sunlands' IR representative. Please go ahead.Yuhua Y ...
NTES(NTES) - 2025 Q3 - Earnings Call Transcript
2025-11-20 13:02
NetEase (NasdaqGS:NTES) Q3 2025 Earnings Call November 20, 2025 07:00 AM ET Company ParticipantsBrandi Piacente - Head of Investor RelationsNone - Company RepresentativeBill Pang - VP of Corporate DevelopmentThomas Chang - Managing DirectorWilliam Ding - CEOJialong Shi - Managing DirectorConference Call ParticipantsYu Qingzeng - AnalystFelix Liu - Lead Analyst and Executive DirectorRitchie Sun - Equity Research AnalystAlicia Yap - Equity Research AnalystLincoln Kong - Equity Research AnalystOperatorGood day ...
Sunlands(STG) - 2025 Q3 - Earnings Call Transcript
2025-11-20 13:02
Sunlands Technology Group (NYSE:STG) Q3 2025 Earnings Call November 20, 2025 07:00 AM ET Company ParticipantsTongbo Liu - CEOYuhua Ye - Head of Investor RelationsHangyu Li - CFOOperatorLadies and gentlemen, thank you for standing by, and welcome to Sunlands' third quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. Today's conference call is being recorded. I will now turn the call over to your host today, Yuhua, Sunlands' IR representative. Please go ahead.Yuhua Y ...